What’s new

Find all new and updated information published on our website in one place below. Filters are available to narrow results down based on your interests, such as whether it relates to human or veterinary medicines or specific topics. Information on medicines and related procedures includes a reference to relevant substances: INN or common name, active substance, and English common name for herbal products. This overview covers up to two months back.

As of 1 October 2025, information on medicines and related procedures includes a reference to relevant substances: INN or common name, active substance, and English common name for herbal products.

Results (496)

Date	Content	Status
30/09/2025	Document: Veterinary pre-submission meeting request form - in accordance with Regulation (EU) No 2019/6	Updated
30/09/2025	Medicine: Bosulif bosutinib	Updated
30/09/2025	Page: Quality of medicines questions and answers: Part 1	Updated
30/09/2025	Event: EMA multi-stakeholder workshop on the clinical evaluation of therapeutic radiopharmaceuticals in oncology	Updated
30/09/2025	Medicine: Evrenzo roxadustat	Updated
30/09/2025	Document: Minutes of the CAT meeting 12-14 August 2025 - written procedure	New
30/09/2025	Medicine: Micardis telmisartan	Updated
30/09/2025	Medicine: Deferasirox Accord deferasirox	Updated
30/09/2025	Document: Minutes of the CAT meeting 16-18 July 2025	New
30/09/2025	Document: List of centrally authorised products with safety-related changes to the product information	Updated
30/09/2025	Medicine: Lynparza olaparib	Updated
30/09/2025	Document: Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)	Updated
30/09/2025	Medicine: Sitagliptin / Metformin hydrochloride Mylan sitagliptin hydrochloride monohydrate; metformin hydrochloride	Updated
30/09/2025	Medicine: Orkambi lumacaftor; ivacaftor	Updated
30/09/2025	Medicine: Maapliv amino acids	Updated
30/09/2025	Medicine: Siklos hydroxycarbamide	Updated
30/09/2025	PSUSA: PSUSA/00010432/202410 - periodic safety update report single assessment timolol (systemic use)	New
30/09/2025	Medicine: Riltrava Aerosphere formoterol fumarate dihydrate; glycopyrronium; budesonide	Updated
30/09/2025	Medicine: Jevtana cabazitaxel	Updated
30/09/2025	Medicine: Hirobriz Breezhaler indacaterol	Updated
30/09/2025	Medicine: Sorafenib Accord sorafenib	Updated
30/09/2025	Medicine: Wegovy semaglutide	Updated
30/09/2025	Medicine: Rybelsus semaglutide	Updated
30/09/2025	Medicine: Orgovyx relugolix	Updated
30/09/2025	Medicine: Oslif Breezhaler indacaterol	Updated
30/09/2025	Medicine: Ozempic semaglutide	Updated
30/09/2025	Medicine: Onbrez Breezhaler indacaterol	Updated
30/09/2025	Page: Clinical evaluation of medicinal products intended for treatment of hepatitis B - Scientific guideline	Updated
30/09/2025	Document: Draft guideline on the clinical evaluation of medicinal products intended for the treatment of chronic hepatitis B (CHB) - Revision 1	New
30/09/2025	Page: Clinical investigation of medicinal products for the treatment of psoriatic arthritis - Scientific guideline	Updated
30/09/2025	Document: Draft guideline on clinical investigation of medicinal products for the treatment of psoriatic arthritis - Revision 1	New
30/09/2025	Event: Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting September 2025	Updated
30/09/2025	Post-authorisation: Remsima - opinion on variation to marketing authorisation infliximab	New
30/09/2025	Document: Concept paper on new guidance on the clinical investigation of medicinal products for the treatment of idiopathic pulmonary fibrosis (IPF)	New
30/09/2025	Page: Clinical investigation of medicinal products for the treatment of idiopathic pulmonary fibrosis (IPF) - Scientific guideline	New
30/09/2025	Medicine: Usrenty ustekinumab	Updated
29/09/2025	Medicine: Hexyon diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed)	Updated
29/09/2025	Medicine: Evrysdi risdiplam	Updated
29/09/2025	Medicine: Retacrit epoetin zeta	Updated
29/09/2025	Event: Clinical Trials Information System (CTIS): Walk-in clinic September 2025	Updated
29/09/2025	Medicine: Hexacima diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed)	Updated
29/09/2025	Shortage: Human normal immunoglobulins human normal immunoglobulins	Updated
29/09/2025	Medicine: Deferasirox Mylan deferasirox	Updated
29/09/2025	Medicine: Zefylti filgrastim	Updated
29/09/2025	Medicine: Truxima rituximab	Updated
29/09/2025	Page: Patients' and Consumers' Working Party	Updated
29/09/2025	Document: Agenda of the PRAC meeting 29 September - 2 October 2025	New
29/09/2025	Medicine: Yesafili aflibercept	Updated
29/09/2025	Document: Minutes of the HMPC meeting 7-9 July 2025	New
29/09/2025	Medicine: Zurzuvae zuranolone	Updated
29/09/2025	Page: Artificial intelligence	Updated
29/09/2025	Medicine: Empliciti elotuzumab	Updated
29/09/2025	Medicine: ellaOne ulipristal acetate	Updated
29/09/2025	Document: HMA-EMA joint Network Data Steering Group meeting - 17 July 2025	New
29/09/2025	Medicine: Bortezomib Accord bortezomib	Updated
29/09/2025	Document: List of signals discussed at PRAC since September 2012	Updated
29/09/2025	Page: PRAC recommendations on safety signals	Updated
29/09/2025	Document: PRAC recommendations on signals adopted at the 1-4 September 2025 PRAC meeting	New
29/09/2025	Document: New product information wording: extracts from PRAC recommendations on signals adopted at the 1-4 September 2025 PRAC	New
29/09/2025	Medicine: Blitzima rituximab	Updated
29/09/2025	Page: Eligible patients and consumers organisations	Updated
29/09/2025	News: A path to better include patients’ perspectives in the regulation of medicines	New
29/09/2025	Medicine: Eliquis apixaban	Updated
29/09/2025	Medicine: Yuflyma adalimumab	Updated
29/09/2025	Medicine: Xalkori crizotinib	Updated
26/09/2025	Medicine: Ibandronic acid Accord ibandronic acid	Updated
26/09/2025	Medicine: Tigecycline Accord tigecycline	Updated
26/09/2025	Document: Minutes of the COMP meeting 15-17 July 2025	New
26/09/2025	Medicine: Dovato dolutegravir; lamivudine	Updated
26/09/2025	Event: Enpr-EMA Coordinating Group and networks meeting June 2025	New
26/09/2025	Page: List of medicines under additional monitoring	Updated
26/09/2025	Medicine: Prasugrel Viatris (previously Prasugrel Mylan) prasugrel	Updated
26/09/2025	Medicine: Hizentra human normal immunoglobulin (SCIg)	Updated
26/09/2025	Medicine: Voranigo vorasidenib	Updated
26/09/2025	Document: Minutes - PDCO minutes of the 22-25 July 2025 meeting	New
26/09/2025	Document: List of medicinal products under additional monitoring	Updated
26/09/2025	Document: List of medicinal products under additional monitoring	Updated
26/09/2025	Medicine: Eylea aflibercept	Updated
26/09/2025	Event: Industry stakeholder webinar on revised environmental risk assessment guideline for medicinal products for human use - 1 year experience	New
26/09/2025	Medicine: Grastofil filgrastim	Updated
26/09/2025	Event: European Platform for Regulatory Science Research meeting September 2025	Updated
26/09/2025	Page: PRIME: priority medicines	Updated
26/09/2025	Document: Recommendations on eligibility to PRIME scheme adopted at the CHMP meeting of 15-18 September 2025	New
26/09/2025	Document: List of medicines currently in PRIME scheme	Updated
25/09/2025	Medicine: Alhemo concizumab	Updated
25/09/2025	PSUSA: PSUSA/00010312/202501 - periodic safety update report single assessment omega-3-acid ethyl esters 90	New
25/09/2025	Medicine: Zoledronic acid Teva zoledronic acid	Updated
25/09/2025	Page: Innovation Task Force briefing meetings	Updated
25/09/2025	Document: List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)	Updated
25/09/2025	Shortage: Ecalta anidulafungin	Updated
25/09/2025	Page: Medicine Shortages Single Point of Contact (SPOC) Working Party	Updated
25/09/2025	Referral: Azithromycin-containing medicinal products for systemic use - referral azithromycin	Updated
25/09/2025	Medicine: Revolade eltrombopag	Updated
25/09/2025	Medicine: Equilis EHV 1+4 Equine herpesvirus vaccine (inactivated)	New
25/09/2025	Medicine: Xaluprine (previously Mercaptopurine Nova Laboratories) mercaptopurine	Updated
25/09/2025	Medicine: Kisqali ribociclib	Updated
25/09/2025	Medicine: Karvezide irbesartan; hydrochlorothiazide	Updated
25/09/2025	Medicine: CoAprovel irbesartan; hydrochlorothiazide	Updated
25/09/2025	PIP: EMEA-002740-PIP03-24 - paediatric investigation plan lenacapavir sodium	New
25/09/2025	Medicine: Padcev enfortumab vedotin	Updated
25/09/2025	Medicine: ProQuad measles, mumps, rubella and varicella vaccine (live)	Updated
25/09/2025	Medicine: Kymriah tisagenlecleucel	Updated
25/09/2025	Medicine: Riulvy tegomil fumarate	Updated
25/09/2025	Medicine: Lacosamide Adroiq lacosamide	Updated
25/09/2025	Medicine: Sugammadex Adroiq sugammadex	Updated
25/09/2025	Medicine: Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris emtricitabine; rilpivirine; tenofovir alafenamide	Updated
25/09/2025	Document: Pharmacovigilance-related regulatory recommendations for centrally authorised veterinary medicinal products during 2025	Updated
25/09/2025	Page: Product-specific bioequivalence guidance	Updated
25/09/2025	Document: Eltrombopag film-coated tablets 12.5 mg, 25 mg, 50 mg, 75 mg and powder for oral suspension 25 mg product-specific bioequivalence guidance	New
25/09/2025	Document: Melatonin prolonged release tablets 2 mg product-specific bioequivalence guidance	New
24/09/2025	Document: Procedural advice on publication of information on withdrawals of marketing authorisation and variation applications for veterinary medicinal products	New
24/09/2025	Medicine: Ixchiq Chikungunya vaccine (live)	Updated
24/09/2025	Event: Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - September 2025	Updated
24/09/2025	News: New co-chairs elected for working parties for healthcare professionals and for patients and consumers	New
24/09/2025	Medicine: Korjuny catumaxomab	Updated
24/09/2025	Medicine: Steqeyma ustekinumab	Updated
24/09/2025	Medicine: Avtozma tocilizumab	Updated
24/09/2025	Medicine: Rinvoq upadacitinib	Updated
24/09/2025	Medicine: Vaxchora cholera vaccine, oral, live	Updated
24/09/2025	Medicine: Stoboclo denosumab	Updated
24/09/2025	Document: Timetable: Post-authorisation measure (PAM) assessed by CAT	Updated
24/09/2025	Document: Timetable: Post-authorisation measure (PAM) Paediatric art. 46 submission - ATMP	Updated
24/09/2025	Document: Timetable: Post-authorisation measure (PAM) Paediatric art. 46 submission	Updated
24/09/2025	Document: Timetable: Post-authorisation measures (PAMs) assessed by PRAC - ATMP	Updated
24/09/2025	Document: Timetable: Post-authorisation measure (PAM) assessed by CHMP	Updated
24/09/2025	Page: Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG)	Updated
24/09/2025	Document: Mandate and objectives for the Working Group of the MSSG on the European Shortages Monitoring Platform (ESMP)	New
24/09/2025	Document: Mandate and objectives for the Working Group of the MSSG on the Voluntary Solidarity Mechanism and Policy	New
24/09/2025	Document: Mandate and objectives for the Working Group of the MSSG on the Vulnerability Analysis Methodology	New
24/09/2025	Document: Minutes of the 128th meeting of the EMA Management Board: 11-12 June 2025	New
24/09/2025	Document: Categorisation of antibiotics in the European Union - Answer to the request from the European Commission for updating the scientific advice on the impact on public health and animal health of the use of antibiotics in animals	Updated
24/09/2025	Document: Infographic - Categorisation of antibiotics for use in animals for prudent and responsible use	Updated
23/09/2025	Document: Scientific recommendations on classification of advanced therapy medicinal products	Updated
23/09/2025	Medicine: Olanzapine Apotex olanzapine	Updated
23/09/2025	Event: Quarterly System Demo – Q3 2025	Updated
23/09/2025	Event: Committee for Advanced Therapies (CAT) workshop on gene editing	Updated
23/09/2025	PSUSA: PSUSA/00001413/202412 - periodic safety update report single assessment flumazenil	New
23/09/2025	DHPC: Ixchiq - direct healthcare professional communication (DHPC) Chikungunya virus, strain CHIKV LR2006-OPY1, live attenuated	New
23/09/2025	Document: Inclusion/exclusion criteria for the Important Medical Events (IME) list	Updated
23/09/2025	PSUSA: PSUSA/00001587/202501 - periodic safety update report single assessment haloperidol	New
23/09/2025	Document: Timetable: Post-authorisation safety study (PASS) protocols and final results	Updated
23/09/2025	Document: Timetable: Periodic safety update report (PSUR) and PSUR single assessment (PSUSA)	Updated
23/09/2025	Document: Timetable: Periodic safety update report (PSUR) and PSUR single assessment (PSUSA) - Advanced therapy medicinal products (ATMPs)	Updated
23/09/2025	Medicine: Alyftrek deutivacaftor / tezacaftor / vanzacaftor	Updated
23/09/2025	Document: Start of procedure: Type II variation - Extension of indication under evaluation by the CHMP (22 August 2025 - 18 September 2025)	New
23/09/2025	Document: Request to the CVMP for classification of a veterinary medicinal product as intended for a limited market according to Article 4(29) and for eligibility for authorisation according to Article 23 (Applications for limited markets)	Updated
23/09/2025	Document: Engineered living materials for in situ production of therapeutics - EU-IN Horizon Scanning Report	New
23/09/2025	Medicine: Gilenya fingolimod	Updated
23/09/2025	Medicine: Vizamyl flutemetamol (18F)	Updated
23/09/2025	Medicine: Pelmeg pegfilgrastim	Updated
23/09/2025	Medicine: Cegfila (previously Pegfilgrastim Mundipharma) pegfilgrastim	Updated
23/09/2025	News: New targets for clinical trials in Europe	New
23/09/2025	News: Use of paracetamol during pregnancy unchanged in the EU	New
23/09/2025	Document: MedDRA important medical event terms list - version 28.1	Updated
22/09/2025	Event: Training session on human variations web-based electronic application form (eAF) for CAPs	Updated
22/09/2025	News: New variations guidelines to streamline lifecycle management of medicines	Updated
22/09/2025	Page: Guidance on the application of the revised variations framework	Updated
22/09/2025	Document: Agenda of the HMPC meeting 22-24 September 2025	New
22/09/2025	Medicine: Romvimza vimseltinib	Updated
22/09/2025	Medicine: Pyzchiva ustekinumab	Updated
22/09/2025	Medicine: Jayempi azathioprine	Updated
22/09/2025	Document: CHMP PROM minutes for the meeting on 17 March 2025	New
22/09/2025	Document: Agenda – Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 24 September 2025	New
22/09/2025	Herbal: Combination: Species pectorales - herbal medicinal product Herbal tea combinations for use in cough and cold	Updated
22/09/2025	Document: Mandate, objectives, and rules of procedure for working parties under the quality, non-clinical, methodology, clinical and veterinary domains	New
19/09/2025	Event: Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - August 2025	Updated
19/09/2025	Event: First EMA/HMA multi-stakeholder forum on EudraVigilance and signal detection	Updated
19/09/2025	Event: HMA/EMA multi-stakeholder workshop on reporting and qualification of mechanistic models for regulatory assessment	Updated
19/09/2025	Medicine: Epysqli	Updated
19/09/2025	Medicine: Jubbonti denosumab	Updated
19/09/2025	Medicine: Wezenla ustekinumab	Updated
19/09/2025	Medicine: Calquence acalabrutinib	Updated
19/09/2025	Medicine: Ordspono odronextamab	Updated
19/09/2025	Medicine: Trixeo Aerosphere formoterol; glycopyrronium bromide; budesonide	Updated
19/09/2025	Medicine: Tepkinly epcoritamab	Updated
19/09/2025	Medicine: Ervebo Ebola Zaire vaccine (rVSV∆G-ZEBOV-GP, live)	Updated
19/09/2025	Referral: Ixchiq - referral Chikungunya vaccine (live)	Updated
19/09/2025	Document: EVVet3 EVWeb Production - Release notes	Updated
19/09/2025	Medicine: Enflonsia clesrovimab	New
19/09/2025	Medicine: Imaavy nipocalimab	New
19/09/2025	News: First treatment recommended for rare immunoglobulin-related autoimmune disease	New
19/09/2025	Medicine: Zvogra denosumab	New
19/09/2025	Medicine: Xbonzy denosumab	New
19/09/2025	Medicine: Usgena ustekinumab	New
19/09/2025	Medicine: Rivaroxaban Koanaa rivaroxaban	New
19/09/2025	Medicine: Ponlimsi denosumab	New
19/09/2025	Medicine: Lynkuet elinzanetant	New
19/09/2025	Medicine: Kyinsu insulin icodec; semaglutide	New
19/09/2025	Medicine: Gobivaz golimumab	New
19/09/2025	Medicine: Kefdensis denosumab	New
19/09/2025	Medicine: Denosumab Intas denosumab	New
19/09/2025	Medicine: Degevma denosumab	New
19/09/2025	Medicine: Acvybra denosumab	New
19/09/2025	Medicine: Tuzodi midazolam	New
19/09/2025	Medicine: Omforro midazolam	New
19/09/2025	Medicine: Atropine sulfate FGK atropine	Updated
19/09/2025	Medicine: Lutathera lutetium (177Lu) oxodotreotide	Updated
19/09/2025	News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 15-18 September 2025	New
19/09/2025	Post-authorisation: Norvir - opinion on variation to marketing authorisation ritonavir	New
19/09/2025	Post-authorisation: Tezspire - opinion on variation to marketing authorisation tezepelumab	New
19/09/2025	Post-authorisation: Lunsumio - opinion on variation to marketing authorisation mosunetuzumab	New
19/09/2025	Post-authorisation: Dupixent - opinion on variation to marketing authorisation dupilumab	New
19/09/2025	Post-authorisation: Koselugo - opinion on variation to marketing authorisation selumetinib	New
19/09/2025	Post-authorisation: Bimervax - opinion on variation to marketing authorisation COVID-19 Vaccine (recombinant, adjuvanted); selvacovatein; damlecovatein	New
19/09/2025	Post-authorisation: Uplizna - opinion on variation to marketing authorisation inebilizumab	New
19/09/2025	Post-authorisation: Keytruda - opinion on variation to marketing authorisation pembrolizumab	New
19/09/2025	Post-authorisation: Keytruda - opinion on variation to marketing authorisation pembrolizumab	New
19/09/2025	Document: Antimicrobial Sales and Use (ASU) Platform: Release notes	Updated
19/09/2025	Document: Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) dataload friendly file including deprecated terms	Updated
19/09/2025	Event: EMA Cancer Medicines Forum (CMF) meeting with industry stakeholders on cancer treatment optimisation	Updated
19/09/2025	Page: The procedure to be followed when a batch of a vaccine finished product is suspected to be contaminated with bovine viral diarrhoea virus - Scientific guideline	Updated
19/09/2025	Page: Duration of immunity achieved by veterinary vaccines - Scientific guideline	Updated
19/09/2025	Document: Substances considered as not falling within the scope of Regulation (EC) No. 470/2009, with regard to residues of veterinary medicinal products in foodstuffs of animal origin	Updated
19/09/2025	Document: Procedural advice on appointment and responsibilities of the CVMP rapporteur and co-rapporteur in accordance with Article 140(6) of Regulation (EU) 2019/6, and peer reviewer	Updated
19/09/2025	DHPC: Rapamune - direct healthcare professional communication (DHPC) sirolimus	New
19/09/2025	Referral: Finasteride- and dutasteride-containing medicinal products - referral finasteride; dutasteride	Updated
18/09/2025	Medicine: mResvia Respiratory syncytial virus mRNA vaccine (nucleoside modified)	Updated
18/09/2025	Medicine: Zonegran zonisamide	Updated
18/09/2025	Medicine: Obodence denosumab	Updated
18/09/2025	Medicine: Vfend voriconazole	Updated
18/09/2025	Shortage: Visudyne verteporfin	Updated
18/09/2025	Medicine: Increlex mecasermin	Updated
18/09/2025	Medicine: Lyrica pregabalin	Updated
18/09/2025	Event: ACT EU workshop on ICH E6 R3 (principles and Annex 1)	Updated
18/09/2025	Document: Management Board meeting dates 2026-2027	New
18/09/2025	Event: Q&A clinic on Substance, Organisation, Referentials Management Services	Updated
18/09/2025	Event: Cancer Medicines Forum: June 2025	New
18/09/2025	Medicine: Leqvio inclisiran	Updated
18/09/2025	Medicine: Replagal agalsidase alfa	Updated
18/09/2025	Page: Network Data Steering Group (NDSG)	Updated
18/09/2025	Document: Overview of Network Data Steering Group (NDSG) change management activities 2025-2026	New
17/09/2025	Document: Letter of intent for the submission of a worksharing procedure to the European Medicines Agency according to Article 65 of Regulation (EU) 2019/6	Updated
17/09/2025	Medicine: Jemperli dostarlimab	Updated
17/09/2025	Medicine: Ogluo glucagon	Updated
17/09/2025	Medicine: Roclanda latanoprost / netarsudil	Updated
17/09/2025	Medicine: Abecma idecabtagene vicleucel	Updated
17/09/2025	Medicine: Conexxence denosumab	Updated
17/09/2025	Document: Quick guide to competing interests for EMA experts	New
17/09/2025	Document: Questions and answers on Implementing Regulation (EU) 2025/1466: Amendment of Regulation (EU) No 520/2012 and Conclusion of the Signal Detection in EudraVigilance Pilot by marketing authorisation holders	Updated
17/09/2025	Document: Article 57 product data	Updated
17/09/2025	Medicine: Cabometyx cabozantinib	Updated
17/09/2025	Event: Workshop on a tailored clinical approach in biosimilar development	Updated
17/09/2025	Medicine: Viagra sildenafil	Updated
17/09/2025	Medicine: Revatio sildenafil	Updated
17/09/2025	Medicine: Pregabalin Viatris Pharma (previously Pregabalin Pfizer) pregabalin	Updated
17/09/2025	Page: Worksharing of variations (veterinary medicines)	Updated
17/09/2025	Document: UPD registration guide for UI and API users	Updated
17/09/2025	Medicine: Bomyntra denosumab	Updated
17/09/2025	Medicine: Zirabev bevacizumab	Updated
17/09/2025	EU-M4all: Dengue Tetravalent Vaccine (Live, Attenuated) Takeda - opinion on medicine for use outside EU dengue tetravalent vaccine (live, attenuated)	Updated
17/09/2025	Event: First European Medicines Agency (EMA) and Association of Clinical Research Organizations (ACRO) bilateral meeting	Updated
17/09/2025	Medicine: Vyndaqel tafamidis	Updated
17/09/2025	Medicine: Rapamune sirolimus	Updated
17/09/2025	Medicine: Pemetrexed Pfizer (previously Pemetrexed Hospira) pemetrexed	Updated
17/09/2025	Medicine: Mylotarg gemtuzumab ozogamicin	Updated
17/09/2025	Medicine: Levetiracetam Hospira levetiracetam	Updated
17/09/2025	Medicine: Elrexfio elranatamab	Updated
17/09/2025	Medicine: Daptomycin Hospira daptomycin	Updated
17/09/2025	Medicine: Besponsa inotuzumab ozogamicin	Updated
17/09/2025	Medicine: Emblaveo aztreonam; avibactam	Updated
17/09/2025	Medicine: Attrogy diflunisal	Updated
16/09/2025	Document: EU Implementation Guide (IG) on veterinary medicines product data in the Union Product Database - Chapter 2: Format for the electronic submission of veterinary medicinal product information	Updated
16/09/2025	Medicine: Tevimbra tislelizumab	Updated
16/09/2025	Page: Mpox	Updated
16/09/2025	Orphan: EU/3/07/434 - orphan designation for treatment of Leber's hereditary optic neuropathy idebenone	Updated
16/09/2025	Orphan: EU/3/12/1063 - orphan designation for treatment of multiple myeloma Panobinostat	Updated
16/09/2025	Event: LinkedIn Live: Smarter trials, stronger Europe. New targets for clinical research.	New
16/09/2025	Page: Human Medicines	Updated
16/09/2025	Document: Organisation chart: Human Medicines	Updated
15/09/2025	Medicine: Baqsimi glucagon	Updated
15/09/2025	Medicine: Emselex darifenacin hydrobromide	Updated
15/09/2025	Event: Committee for Medicinal Products for Human Use (CHMP): 15-18 September 2025	Updated
15/09/2025	Document: Annex to agenda of the CHMP meeting 15-18 September 2025	New
15/09/2025	Document: Agenda of the CHMP meeting 15-18 September 2025	New
15/09/2025	Page: Scientific Advisory Group on Immune and Inflammatory Diseases	Updated
15/09/2025	Document: Public call for expression of interest for experts to become members of the European Medicines Agency's Scientific Advisory Group on Immune and Inflammatory Diseases	Updated
15/09/2025	Medicine: Locametz gozetotide	Updated
15/09/2025	Medicine: Thalidomide Lipomed thalidomide	Updated
15/09/2025	Document: Network Portfolio Roadmap	Updated
12/09/2025	Event: European Medicines Agency (EMA) and European Association of Urology (EAU) bilateral meeting	New
12/09/2025	PSUSA: PSUSA/00002398/202411 - periodic safety update report single assessment phosphocreatine	New
12/09/2025	Medicine: Livmarli maralixibat chloride	Updated
12/09/2025	Event: First European Medicines Agency (EMA) and European Association for the Study of Diabetes (EASD) bilateral meeting	New
12/09/2025	News: Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 9-10 September 2025	New
12/09/2025	Medicine: Portela relfovetmab	New
12/09/2025	Post-authorisation: Bravecto TriUNO - opinion on variation to marketing authorisation fluralaner; moxidectin; pyrantel	New
12/09/2025	PSUSA: PSUSA/00001041/202501 - periodic safety update report single assessment cyanocobalamin / diclofenac / pyridoxine / thiamine	New
12/09/2025	Medicine: Velsipity etrasimod	Updated
11/09/2025	PSUSA: PSUSA/00010287/202411 - periodic safety update report single assessment acetylsalicylic acid / bisoprolol	New
11/09/2025	PSUSA: PSUSA/00000427/202412 - periodic safety update report single assessment botulinum toxin a - haemagglutinin complex	New
11/09/2025	Medicine: Taltz ixekizumab	Updated
11/09/2025	Medicine: Axitinib Accord axitinib	Updated
11/09/2025	Medicine: Loqtorzi toripalimab	Updated
11/09/2025	Medicine: Champix varenicline	Updated
11/09/2025	Medicine: Nilotinib Accord nilotinib	Updated
11/09/2025	Medicine: Rukobia fostemsavir	Updated
11/09/2025	Page: Union Product Database	Updated
11/09/2025	Medicine: Rezzayo rezafungin	Updated
11/09/2025	Medicine: Dectova zanamivir	Updated
11/09/2025	Medicine: Ryjunea atropine sulfate	Updated
10/09/2025	Document: PRIME eligibility requests: 2026 deadlines for submission and timetable for assessment	New
10/09/2025	Medicine: Tivicay dolutegravir	Updated
10/09/2025	Medicine: Jakavi ruxolitinib	Updated
10/09/2025	Medicine: Imbruvica ibrutinib	Updated
10/09/2025	Medicine: Spravato esketamine	Updated
10/09/2025	Medicine: Arexvy recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E	Updated
10/09/2025	Medicine: Zonisamide Viatris (previously Zonisamide Mylan) zonisamide	Updated
10/09/2025	News: Management Board formally approves renewal of Executive Director’s mandate	New
10/09/2025	Medicine: Vegzelma bevacizumab	Updated
10/09/2025	Document: Regulatory Procedure Management (RPM) for the Product Lifecycle Management (PLM) - Frequently asked questions	Updated
10/09/2025	Medicine: Hemlibra emicizumab	Updated
10/09/2025	Medicine: Tasmar tolcapone	Updated
10/09/2025	Medicine: Rekambys rilpivirine	Updated
10/09/2025	Medicine: Inflectra infliximab	Updated
10/09/2025	Document: Minutes of the PRAC meeting 7-10 July 2025	New
10/09/2025	PSUSA: PSUSA/00010987/202501 - periodic safety update report single assessment myristalkonium, benzalkonium (vaginal use only)	New
10/09/2025	PSUSA: PSUSA/00001418/202501 - periodic safety update report single assessment flunitrazepam	New
10/09/2025	Document: Regulatory Procedure Management (RPM) for the Product Lifecycle Management (PLM) - Frequently asked questions - tracked changes	New
10/09/2025	PSUSA: PSUSA/00001686/202411 - periodic safety update report single assessment hydromorphone	New
10/09/2025	PSUSA: PSUSA/00000108/202412 - periodic safety update report single assessment human alfa1-proteinase inhibitor (apart from the centrally authorised product)	New
10/09/2025	PSUSA: PSUSA/00010266/202412 - periodic safety update report single assessment varicella-zoster immunoglobuline	New
10/09/2025	PSUSA: PSUSA/00003067/202412 - periodic safety update report single assessment typhoid vaccine (live, attenuated)	New
10/09/2025	PSUSA: PSUSA/00000599/202412 - periodic safety update report single assessment cefotaxime	New
10/09/2025	Event: Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party	Updated
09/09/2025	DHPC: Caspofungin - direct healthcare professional communication (DHPC) caspofungin	New
09/09/2025	Medicine: Vocabria cabotegravir	Updated
09/09/2025	Medicine: Zinforo ceftaroline fosamil	Updated
09/09/2025	Medicine: Revlimid lenalidomide	Updated
09/09/2025	Medicine: Tenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan) tenofovir disoproxil	Updated
09/09/2025	Orphan: EU/3/16/1715 - orphan designation for treatment of inherited retinal dystrophies due to defects in the RPGR gene botaretigene sparoparvovec	Updated
09/09/2025	Medicine: Ecalta anidulafungin	Updated
09/09/2025	Page: Medicine evaluation figures	Updated
09/09/2025	Document: Medicinal products for human use: monthly figures - August 2025	New
09/09/2025	Document: Medicinal products for human use: monthly figures - July 2025	New
09/09/2025	PSUSA: PSUSA/00002172/202412 - periodic safety update report single assessment nitric oxide	New
09/09/2025	Medicine: Equisolon Prednisolone	Updated
09/09/2025	Medicine: Equioxx firocoxib	Updated
09/09/2025	Document: Agenda of the CAT meeting 10-12 September 2025	New
09/09/2025	PSUSA: PSUSA/00010190/202412 - periodic safety update report single assessment amino acid combinations / glucose / triglyceride combinations	New
09/09/2025	Document: Agenda - PDCO agenda of the 9-12 September 2025 meeting	New
09/09/2025	Medicine: Equilis West Nile inactivated chimaeric flavivirus strain YF-WN	Updated
09/09/2025	Medicine: Fungitraxx itraconazole	Updated
09/09/2025	Medicine: Fortekor Plus benazepril; pimobendan	Updated
09/09/2025	Event: Training session on human variations web-based electronic Application Form (eAF) for non-CAPs	Updated
09/09/2025	Medicine: Felpreva emodepside; praziquantel; tigolaner	Updated
09/09/2025	Document: Agenda of the COMP meeting 9-11 September 2025	New
09/09/2025	Medicine: Fatrovax RHD rabbit haemorrhagic disease vaccine (inactivated, recombinant)	Updated
09/09/2025	Medicine: Evant coccidiosis vaccine live for chickens	Updated
09/09/2025	Medicine: Evalon Eimeria acervulina, strain 003; Eimeria brunetti, strain 034; Eimeria maxima, strain 013; Eimeria necatrix, strain 033; Eimeria tenella, strain 004	Updated
09/09/2025	Medicine: Eurican Herpes 205 canine herpes vaccine (inactivated subunit)	Updated
09/09/2025	Medicine: Eryseng Erysipelothrix rhusiopathiae	Updated
09/09/2025	Medicine: Eryseng Parvo porcine parvovirus and Erysipelothrix rhusiopathiae	Updated
09/09/2025	Page: Supporting innovation	Updated
09/09/2025	Document: Portfolio and technology meeting briefing document	Updated
09/09/2025	Event: Patients and Consumers Working Party (PCWP) plenary meeting September 2025	Updated
09/09/2025	Page: Union Product Database: release notes	Updated
09/09/2025	Event: Healthcare Professionals' Working Party (HCPWP) plenary meeting September 2025	Updated
09/09/2025	DHPC: Clozapine - direct healthcare professional communication (DHPC) clozapine	New
09/09/2025	PSUSA: PSUSA/00010402/202501 - periodic safety update report single assessment phenylephrine (ophthalmic formulations)	New
09/09/2025	PSUSA: PSUSA/00001999/202501 - periodic safety update report single assessment metamizole sodium / triacetonamine tosilate	New
08/09/2025	Medicine: Procysbi mercaptamine	Updated
08/09/2025	Medicine: Lopinavir/Ritonavir Viatris (previously Ritonavir Mylan) lopinavir; ritonavir	Updated
08/09/2025	Medicine: Nevanac nepafenac	Updated
08/09/2025	Medicine: Eksunbi ustekinumab	Updated
08/09/2025	Medicine: Yaxwer denosumab	Updated
08/09/2025	Document: Start of procedure: Type II variation - Extension of indication under evaluation by the CHMP (25 July - 21 August 2025)	New
08/09/2025	Document: Start of procedure: Extension of marketing authorisation (25 July - 21 August 2025)	New
08/09/2025	Document: Agenda of the CVMP meeting 9-11 September 2025	New
08/09/2025	Document: Dossier administrative validation checklist for initial marketing authorisation applications by applicants	Updated
08/09/2025	PSUSA: PSUSA/00002359/202501 - periodic safety update report single assessment lidocaine / phenazone	New
08/09/2025	Page: Pre-authorisation guidance	Updated
08/09/2025	Document: Pre-submission request form for a EMA procedure prior to the submission of a marketing authorisation application or Article 58 Application	Updated
08/09/2025	Document: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure	Updated
08/09/2025	Document: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure: document with tracked changes	Updated
08/09/2025	PSUSA: PSUSA/00002849/202411 - periodic safety update report single assessment tapentadol	New
08/09/2025	Event: Global IDMP Working Group (GIDWG) Stakeholder Meeting: 1-3 October 2025	New
08/09/2025	PSUSA: PSUSA/00003162/202501 - periodic safety update report single assessment bendamustine hydrochloride	New
05/09/2025	Medicine: Sephience sepiapterin	Updated
05/09/2025	EU-M4all: Lenacapavir Gilead - opinion on medicine for use outside EU lenacapavir	Updated
05/09/2025	Medicine: Sunosi solriamfetol	Updated
05/09/2025	Medicine: Wakix pitolisant	Updated
05/09/2025	Medicine: Zemcelpro allogeneic umbilical cord-derived CD34- cells, non-expanded; dorocubicel	Updated
05/09/2025	Medicine: Ozawade pitolisant	Updated
05/09/2025	Medicine: Amsparity adalimumab	Updated
05/09/2025	Medicine: Nintedanib Viatris nintedanib	Updated
05/09/2025	Document: Medicine shortage communication (MSC): Victoza 6 mg/mL solution for injection in pre-filled pen (liraglutide)	New
05/09/2025	Medicine: Equilis StrepE live vaccine against Streptococcus equi	Updated
05/09/2025	Medicine: Enteroporc Coli AC neonatal piglet colibacillosis (recombinant, inactivated); Clostridium perfringens vaccine (inactivated)	Updated
05/09/2025	Medicine: Emdocam meloxicam	Updated
05/09/2025	Medicine: Econor valnemulin	Updated
05/09/2025	Referral: Levamisole-containing medicinal products - referral levamisole	New
05/09/2025	News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 1 – 4 September 2025	New
05/09/2025	News: PRAC starts safety review of levamisole, a medicine used to treat parasitic worm infections	New
05/09/2025	PSUSA: PSUSA/00002669/202412 - periodic safety update report single assessment roxithromycin	New
04/09/2025	Medicine: Easotic hydrocortisone aceponate; miconazole nitrate; gentamicin sulfate	Updated
04/09/2025	PSUSA: PSUSA/00002431/202501 - periodic safety update report single assessment pirenoxine	New
04/09/2025	Medicine: Draxxin tulathromycin	Updated
04/09/2025	PSUSA: PSUSA/00002977/202412 - periodic safety update report single assessment tizanidine	New
04/09/2025	Medicine: Cortavance hydrocortisone aceponate	Updated
04/09/2025	Medicine: Contacera meloxicam	Updated
04/09/2025	PSUSA: PSUSA/00010771/202412 - periodic safety update report single assessment anthrax vaccine	New
04/09/2025	PSUSA: PSUSA/00010710/202501 - periodic safety update report single assessment alitretinoin (oral use)	New
04/09/2025	Page: Pre-authorisation guidance under the Veterinary Medicinal Products Regulation (Regulation (EU) 2019/6)	Updated
04/09/2025	Medicine: Coliprotec F4/F18 porcine post-weaning diarrhoea vaccine (live)	Updated
04/09/2025	Medicine: Clynav salmon pancreas disease vaccine (recombinant DNA plasmid)	Updated
04/09/2025	Medicine: Clomicalm clomipramine	Updated
04/09/2025	Medicine: Beyonttra acoramidis	Updated
04/09/2025	Medicine: Eurartesim piperaquine tetraphosphate; artenimol	Updated
04/09/2025	Medicine: Topotecan Hospira topotecan	Updated
04/09/2025	Medicine: Skyclarys omaveloxolone	Updated
04/09/2025	Orphan: EU/3/23/2811 - orphan designation for treatment of ovarian cancer relacorilant	Updated
04/09/2025	Orphan: EU/3/23/2847 - orphan designation for treatment of CSF1R-related leukoencephalopathy human IgG1 (296-cysteine,301-glycine,306-cysteine) monoclonal antibody against TREM2	Updated
04/09/2025	Orphan: EU/3/05/297 - orphan designation for treatment of Duchenne muscular dystrophy adeno-associated viral vector containing a modified U7 snRNA gene	Updated
04/09/2025	Orphan: EU/3/22/2598 - orphan designation for treatment of giant axonal neuropathy adeno-associated virus vector serotype 9 encoding human gigaxonin gene	Updated
04/09/2025	Orphan: EU/3/07/441 - orphan designation for treatment of adrenal insufficiency hydrocortisone	Updated
04/09/2025	Orphan: EU/3/22/2673 - orphan designation for treatment of peripheral T-cell lymphoma nanatinostat; valganciclovir	Updated
04/09/2025	Orphan: EU/3/22/2742 - orphan designation for treatment of diffuse large B-cell lymphoma valganciclovir; nanatinostat	Updated
04/09/2025	Orphan: EU/3/21/2410 - orphan designation for treatment of medullary thyroid carcinoma 2-[6-(6,7-Dimethoxyquinolin-3-yl)pyridin-3-yl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide (zeteletinib)	Updated
04/09/2025	Orphan: EU/3/11/935 - orphan designation for treatment of Friedreich's ataxia Interferon gamma	Updated
04/09/2025	Orphan: EU/3/25/3097 - orphan designation for treatment of haemophagocytic lymphohistiocytosis humanised IgG1 kappa monoclonal antibody against tyrosine-protein phosphatase non-receptor type substrate 1, signal-regulatory protein beta-1 and signal-regulatory protein gamma	New
04/09/2025	Orphan: EU/3/25/3091 - orphan designation for treatment of acute lymphoblastic leukaemia allogeneic peripheral blood-derived T-cells, fratricide-resistant, transduced with a lentivirus vector expressing a chimeric antigen receptor against CD7	New
04/09/2025	Orphan: EU/3/25/3096 - orphan designation for treatment of pancreatic cancer aglatimagene besadenovec	New
04/09/2025	Orphan: EU/3/25/3089 - orphan designation for treatment of non-syndromic inherited retinal dystrophies of the rod-dominant phenotype methotrexate	New
04/09/2025	Orphan: EU/3/25/3083 - orphan designation for treatment of inherited mitochondrial oxidative phosphorylation defects sonlicromanol hydrochloride	New
04/09/2025	Orphan: EU/3/25/3085 - orphan designation for treatment of myelodysplastic syndromes Ivosidenib	New
04/09/2025	Orphan: EU/3/25/3099 - orphan designation for treatment of myasthenia gravis telitacicept	New
04/09/2025	Orphan: EU/3/25/3092 - orphan designation for treatment of Charcot-Marie-Tooth disease curcumin	New
04/09/2025	Orphan: EU/3/25/3086 - orphan designation for treatment of hepatitis E ribavirin	New
04/09/2025	Medicine: Triumeq abacavir; dolutegravir; lamivudine	Updated
04/09/2025	Orphan: EU/3/25/3090 - orphan designation for treatment of ovarian cancer avutometinib; defactinib	New
04/09/2025	Orphan: EU/3/25/3084 - orphan designation for treatment of Duchenne muscular dystrophy palmitoyl-conjugated tricyclo-DNA antisense oligonucleotide 5'-Palm-C6-*GGA GAT GgC AGT TTC-3	New
04/09/2025	Orphan: EU/3/25/3095 - orphan designation for treatment of Duchenne muscular dystrophy luminol monosodium	New
04/09/2025	Page: Academia	Updated
04/09/2025	Orphan: EU/3/25/3098 - orphan designation for treatment of hereditary haemorrhagic telangiectasia human bispecific monoclonal antibody targeting ALK1 and BMPRII	New
04/09/2025	Orphan: EU/3/25/3101 - orphan designation for treatment of autosomal dominant polycystic kidney disease adeno-associated viral vector serotype 9 containing the human CTNNB1 gene	New
04/09/2025	Orphan: EU/3/25/3093 - orphan designation for treatment of autosomal dominant polycystic kidney disease octreotide hydrochloride	New
04/09/2025	Orphan: EU/3/25/3087 - orphan designation for treatment of dystrophic myotonia phosphorodiamidate morpholino oligonucleotide against the CUG repeat expansion of the DMPK gene mRNA transcript, conjugated to a cell penetrating peptide	New
04/09/2025	Orphan: EU/3/25/3094 - orphan designation for treatment of idiopathic inflammatory myopathy resecabtagene autoleucel	New
04/09/2025	Orphan: EU/3/25/3100 - orphan designation for treatment of primary sclerosing cholangitis Elafibranor	New
04/09/2025	Orphan: EU/3/25/3088 - orphan designation for treatment of myelofibrosis nuvisertib	New
03/09/2025	Document: Rules for reimbursement of expenses for delegates attending meetings with effect from 17 March 2023	Updated
03/09/2025	Medicine: Clevor ropinirole	Updated
03/09/2025	Medicine: Chanhold selamectin	Updated
03/09/2025	PSUSA: PSUSA/00002153/202412 - periodic safety update report single assessment nicotine	New
03/09/2025	Medicine: Baycox Iron toltrazuril; iron (III) ion	Updated
03/09/2025	Medicine: Enzalutamide Viatris enzalutamide	Updated
03/09/2025	Medicine: Lokelma sodium zirconium cyclosilicate	Updated
03/09/2025	Medicine: Casgevy exagamglogene autotemcel	Updated
03/09/2025	Medicine: Rapiscan regadenoson	Updated
03/09/2025	Medicine: Omvoh mirikizumab	Updated
03/09/2025	Medicine: Junod denosumab	Updated
03/09/2025	Medicine: Yeytuo lenacapavir	Updated
03/09/2025	News: Warning about sharp rise in illegal medicines sold in the EU	New
03/09/2025	Document: Verification application form	New
03/09/2025	Medicine: Poteligeo mogamulizumab	Updated
03/09/2025	Medicine: Tibsovo ivosidenib	Updated
03/09/2025	Medicine: Hepcludex bulevirtide	Updated
03/09/2025	Document: Template for submission of comments for the Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) standard list for EudraVigilance Veterinary (EVVet)	Updated
03/09/2025	Medicine: Ryzneuta efbemalenograstim alfa	Updated
02/09/2025	Medicine: Azarga brinzolamide; timolol	Updated
02/09/2025	Medicine: Simbrinza brinzolamide; brimonidine tartrate	Updated
02/09/2025	Document: Appendix 1: Acceptable intakes established for N-nitrosamines	Updated
02/09/2025	Medicine: Ebilfumin oseltamivir	Updated
02/09/2025	Medicine: Caelyx pegylated liposomal doxorubicin	Updated
02/09/2025	Medicine: Syvazul BTV bluetongue virus vaccine (inactivated) (multistrain: 1-2 strains out of a set of 3)	Updated
02/09/2025	Medicine: Syvazul BTV 3 bluetongue virus vaccine (inactivated)	Updated
02/09/2025	Medicine: Daxocox enflicoxib	Updated
02/09/2025	Medicine: Nobivac LeuFel feline leukaemia vaccine (inactivated)	Updated
02/09/2025	Medicine: Nobivac Myxo-RHD Plus myxomatosis and rabbit haemorrhagic viral disease vaccine (live recombinant)	Updated
02/09/2025	Medicine: Leucogen feline leukaemia vaccine (inactivated)	Updated
02/09/2025	Document: Decision of the Executive Director on rules governing the secondment of national experts to the EMA (from 1 October 2025)	New
02/09/2025	Medicine: Eravac rabbit haemorrhagic disease vaccine (inactivated)	Updated
02/09/2025	Medicine: Startvac adjuvanted inactivated vaccine for cattle against Staphylococcus aureus, coliforms and coagulase-negative staphylococci	Updated
02/09/2025	Medicine: Suvaxyn CSF Marker classical swine fever vaccine (live recombinant)	Updated
02/09/2025	Medicine: NexGard afoxolaner	Updated
02/09/2025	Medicine: Nexgard Spectra afoxolaner; milbemycin oxime	Updated
02/09/2025	Medicine: Fluralaner Intervet fluralaner	Updated
02/09/2025	Medicine: Innovax-ND-IBD-ILT avian infectious laryngotracheitis; infectious bursal disease; Marek's disease vaccine (live recombinant); Newcastle disease virus vaccine (inactivated)	Updated
02/09/2025	Medicine: Blenrep belantamab mafodotin	Updated
02/09/2025	Medicine: Nobilis Multriva Gm+REOm avian infectious bursal disease; avian reovirus vaccine (inactivated)	Updated
02/09/2025	Medicine: Nobilis Multriva IBm+ND avian infectious bronchitis virus; Newcastle disease virus vaccine (inactivated)	Updated
02/09/2025	Medicine: Pluvicto lutetium (177Lu) vipivotide tetraxetan	Updated
01/09/2025	Document: Agenda of the PRAC meeting 1-4 September 2025	New
01/09/2025	Medicine: Zenrelia ilunocitinib	Updated
01/09/2025	Medicine: Bravecto CombiUNO fluralaner; milbemycin oxime	Updated
01/09/2025	Medicine: Numelvi atinvicitinib	Updated
01/09/2025	Medicine: Jcovden (previously COVID-19 Vaccine Janssen) COVID-19 vaccine (Ad26.COV2-S [recombinant])	Updated
01/09/2025	News: EMA and WHO mark ten years of collaboration to advance global access to medicines	New
01/09/2025	Page: World Health Organization (WHO)	Updated
01/09/2025	Document: Infosheet: European Medicines Agency - World Health Organization collaboration and partnership	New
01/09/2025	Page: Transfer of data on suspected adverse reactions to WHO	New
01/09/2025	Document: Applications for new human medicines under evaluation: September 2025	New
01/09/2025	Page: Industry Standing Group meetings	Updated
01/09/2025	Event: 14th Industry Standing Group (ISG) meeting	New
01/09/2025	Page: Administration and Corporate Management	Updated
01/09/2025	Document: Organisation chart: Administration and Corporate Management	Updated

What’s new

Filter by

Results (496)